The honeymoon phase of generative artificial intelligence (GenAI) is officially over, and businesses are taking a more measured approach to its adoption. A recent survey by Lucidworks reveals that companies are increasingly wary of deploying GenAI tools due to concerns over accuracy, security, and high costs. Despite the initial enthusiasm, only a few businesses have managed to advance past the pilot phase since the technology’s emergence in 2022. The survey highlights the significant variation in technology adoption across industries, with financial services and B2B businesses leading the way, while hospitality and real estate services lag behind. The primary factor for the stagnation in investments is the lack of financial benefit, with 42% of companies yet to see a significant benefit from their GenAI initiatives.
My take on this is that the GenAI bubble has finally burst, and businesses are coming to terms with the harsh reality of its limitations. The tech giants selling GenAI products are also aware of the deployment difficulties and are softening customer expectations. The high costs of running the software, accuracy issues, and difficulty in determining its value are major concerns for businesses. The survey’s findings are a wake-up call for the industry, and it’s time to rethink the hype surrounding GenAI.
